Detalhe da pesquisa
1.
Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection.
Eur J Immunol
; 54(1): e2350633, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37799110
2.
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
Br J Dermatol
; 190(3): 355-363, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846976
3.
Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis.
J Eur Acad Dermatol Venereol
; 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38411353
4.
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.
J Eur Acad Dermatol Venereol
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860729
5.
Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice.
J Eur Acad Dermatol Venereol
; 37(10): 2004-2015, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246505
6.
Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Dermatol Ther
; 35(2): e15231, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820971
7.
Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis.
Dermatology
; 238(4): 620-629, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823247
8.
Vegetative lesions associated with inhaled cocaine use.
Clin Exp Dermatol
; 47(8): 1586-1588, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426445
9.
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry.
J Am Acad Dermatol
; 83(1): 139-150, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213306
10.
Real World SB4 (Etanercept Biosimilar) Use in Patients With Psoriasis: Data from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
J Drugs Dermatol
; 19(3): 316-318, 2020 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32550686
11.
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients.
J Eur Acad Dermatol Venereol
; 38(1): e26-e28, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561934
12.
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
J Eur Acad Dermatol Venereol
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421043
13.
Conventional therapy in psoriasis. Lost in translation?
Br J Dermatol
; 188(5): 589-590, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763046
14.
Differences in epidemiology, comorbidities and treatment choice between plaque psoriasis and pustular psoriasis: results from the BIOBADADERM registry.
Br J Dermatol
; 187(5): 817-820, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35819180
15.
Development of morphea during Nivolumab treatment.
Australas J Dermatol
; 63(2): 269-271, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325471
16.
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
J Am Acad Dermatol
; 84(2): 513-517, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33122022
17.
The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study.
J Am Acad Dermatol
; 82(3): 738-741, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306726
18.
Ichthyosiforme Hautveränderungen und Gesichtserythem nach Behandlung mit Ponatinib.
J Dtsch Dermatol Ges
; 18(7): 743-748, 2020 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-32713158
19.
Ichthyosiform eruption and facial erythema secondary to ponatinib therapy.
J Dtsch Dermatol Ges
; 18(7): 743-747, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589336
20.
Biosimilar and interchangeable: Inseparable scientific concepts?
Br J Clin Pharmacol
; 85(11): 2460-2463, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486117